» Articles » PMID: 16230561

Distinguishing Androgenetic Alopecia from Chronic Telogen Effluvium when Associated in the Same Patient: a Simple Noninvasive Method

Overview
Journal Arch Dermatol
Specialty Dermatology
Date 2005 Oct 19
PMID 16230561
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Distinguishing chronic telogen effluvium (CTE) from androgenetic alopecia (AGA) may be difficult especially when associated in the same patient.

Observations: One hundred consecutive patients with hair loss who were clinically diagnosed as having CTE, AGA, AGA + CTE, or remitting CTE. Patients washed their hair in the sink in a standardized way. All shed hairs were counted and divided "blindly" into 5 cm or longer, intermediate length (>3 to <5 cm), and 3 cm or shorter. The latter were considered telogen vellus hairs, and patients having at least 10% of them were classified as having AGA. We assumed that patients shedding 200 hairs or more had CTE. The kappa statistic revealed, however, that the best concordance between clinical and numerical diagnosis (kappa = 0.527) was obtained by setting the cutoff shedding value at 100 hairs or more. Of the 100 patients, 18 with 10% or more of hairs that were 3 cm or shorter and who shed fewer than 100 hairs were diagnosed as having AGA; 34 with fewer than 10% of hairs that were 3 cm or shorter and who shed at least 100 hairs were diagnosed as having CTE; 34 with 10% or more of hairs that were 3 cm or shorter and who shed at least 100 hairs were diagnosed as having AGA + CTE; and 14 with fewer than 10% of hairs that were 3 cm or shorter and who shed fewer than 100 hairs were diagnosed as having CTE in remission.

Conclusion: This method is simple, noninvasive, and suitable for office evaluation.

Citing Articles

Chronic Telogen Effluvium: Is it a Distinct Condition? A Systematic Review.

Daunton A, Harries M, Sinclair R, Paus R, Tosti A, Messenger A Am J Clin Dermatol. 2023; 24(4):513-520.

PMID: 37052778 DOI: 10.1007/s40257-023-00760-0.


Study of the Thyroid Profile of Patients with Alopecia.

Popa A, Carsote M, Cretoiu D, Dumitrascu M, Nistor C, Sandru F J Clin Med. 2023; 12(3).

PMID: 36769763 PMC: 9918246. DOI: 10.3390/jcm12031115.


Alopecia areata incognita: clinical characteristics and use of the Sinclair shedding scale.

Collins M, Ali S, Kelley K, Senna M Int J Womens Dermatol. 2023; 8(4):e067.

PMID: 36601598 PMC: 9788966. DOI: 10.1097/JW9.0000000000000067.


Hair Shedding Evaluation for Alopecia: A Refined Wash Test.

Li X, Wang X, Wang C, Zhang J, Zhou C Clin Cosmet Investig Dermatol. 2022; 15:117-126.

PMID: 35115799 PMC: 8801509. DOI: 10.2147/CCID.S347898.


The Effects of Smoking on Hair Health: A Systematic Review.

Babadjouni A, Foulad D, Hedayati B, Evron E, Mesinkovska N Skin Appendage Disord. 2021; 7(4):251-264.

PMID: 34307472 PMC: 8280411. DOI: 10.1159/000512865.